Skip to main content

GLP1RAs Tied to Greater Risk of Diabetic Retinopathy Progression Than SGLT2is

Medically reviewed by Carmen Pope, BPharm. Last updated on July 26, 2024.

By Lori Solomon HealthDay Reporter

FRIDAY, July 26, 2024 -- In patients with diabetes and established diabetic retinopathy (DR), treatment with glucagon-like peptide 1 receptor agonists (GLP1RAs) is associated with increased risks of DR progression compared with sodium-glucose cotransporter 2 inhibitors (SGLT2is), according to a study published online July 19 in Diabetes, Obesity and Metabolism.

Donna Shu-Han Lin, M.D., from Shin Kong Wu Ho-Su Memorial Hospital in Taipei, Taiwan, and colleagues examined the effects of GLP1RAs and SGLT2is on the development or progression of DR. Analysis included 1,517 patients treated with a GLP1RA with DR and 9,549 without DR and 3,034 patients treated with an SGLT2i with DR and 19,098 without DR.

The researchers found that in patients with preexisting DR, the incidence of any DR progression event was significantly higher in the GLP1RA group than the SGLT2i group (subdistribution hazard ratio, 1.50). This risk of progression was driven by increased risk of tractional RD. In patients without DR at baseline, the groups had similar risk for all ocular outcomes.

"The hazards of retinal events associated with GLP1RA use are probably accentuated in those with a higher baseline risk; whether this is related to more rapid glycemic control with GLP1RA use remains to be elucidated," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted July 2024

Read this next

Pulmonary Embolism More Common in Children Than Previously Thought

THURSDAY, May 22, 2025 -- Pulmonary embolism (PE) is more common in children than previously thought, according to a study presented at the American Thoracic Society 2025...

Half of Youth-Serving Clinicians Screen for Substance Use Disorder at Every Well Visit

THURSDAY, May 22, 2025 -- Just over half of youth-serving clinicians report that they routinely screen adolescents for substance use disorders (SUDs) at every well visit...

Many Heart Failure Patients Do Not See a Cardiologist Annually

THURSDAY, May 22, 2025 -- About 40 percent of patients with heart failure diagnosis do not see a cardiologist annually, according to a study published online May 18 in the...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.